These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 12602902

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
    Tworoger SS, Chubak J, Aiello EJ, Ulrich CM, Atkinson C, Potter JD, Yasui Y, Stapleton PL, Lampe JW, Farin FM, Stanczyk FZ, McTiernan A.
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
    Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA.
    J Natl Cancer Inst; 2004 Jun 16; 96(12):936-45. PubMed ID: 15199113
    [Abstract] [Full Text] [Related]

  • 6. Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.
    Abrahamson PE, Tworoger SS, Aiello EJ, Bernstein L, Ulrich CM, Gilliland FD, Stanczyk FZ, Baumgartner R, Baumgartner K, Sorensen B, Ballard-Barbash R, McTiernan A.
    Breast Cancer Res Treat; 2007 Sep 16; 105(1):45-54. PubMed ID: 17077994
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
    Diergaarde B, Potter JD, Jupe ER, Manjeshwar S, Shimasaki CD, Pugh TW, Defreese DC, Gramling BA, Evans I, White E.
    Cancer Epidemiol Biomarkers Prev; 2008 Jul 16; 17(7):1751-9. PubMed ID: 18628428
    [Abstract] [Full Text] [Related]

  • 9. Genetic determinants of mammographic density.
    Haiman CA, Bernstein L, Berg D, Ingles SA, Salane M, Ursin G.
    Breast Cancer Res; 2002 Jul 16; 4(3):R5. PubMed ID: 12052257
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women.
    Miyoshi Y, Noguchi S.
    Biomed Pharmacother; 2003 Dec 16; 57(10):471-81. PubMed ID: 14637391
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
    Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, Brennan P, Boffetta P, Yoshida T.
    Int J Cancer; 2009 Aug 15; 125(4):837-43. PubMed ID: 19415745
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY.
    Cancer Res; 1999 Oct 01; 59(19):4870-5. PubMed ID: 10519398
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition.
    Mitchell ES, Farin FM, Stapleton PL, Tsai JM, Tao EY, Smith-DiJulio K, Woods NF.
    Menopause; 2008 Oct 01; 15(1):105-11. PubMed ID: 17589376
    [Abstract] [Full Text] [Related]

  • 15. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
    Dumas I, Diorio C.
    BMC Cancer; 2010 Nov 22; 10():636. PubMed ID: 21092186
    [Abstract] [Full Text] [Related]

  • 16. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism.
    Mitrunen K, Hirvonen A.
    Mutat Res; 2003 Sep 22; 544(1):9-41. PubMed ID: 12888106
    [Abstract] [Full Text] [Related]

  • 17. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
    Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.
    Breast Cancer Res Treat; 2009 Mar 22; 114(2):327-38. PubMed ID: 18629629
    [Abstract] [Full Text] [Related]

  • 18. Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer.
    Hong CC, Thompson HJ, Jiang C, Hammond GL, Tritchler D, Yaffe M, Boyd NF.
    Breast Cancer Res Treat; 2004 Dec 22; 88(3):217-30. PubMed ID: 15609124
    [Abstract] [Full Text] [Related]

  • 19. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
    Rebbeck TR, Troxel AB, Wang Y, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Bunin G, DeMichele A, Rubin SC, Baumgarten M, Berlin M, Schinnar R, Berlin JA, Strom BL.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1311-20. PubMed ID: 16985250
    [Abstract] [Full Text] [Related]

  • 20. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.
    Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, Oscarson M, Ingelman-Sundberg M, Persson I.
    Carcinogenesis; 2003 Sep 20; 24(9):1533-9. PubMed ID: 12844487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.